stockportfolio.pro
Ligand Pharmaceuticals Incorporated Shares Outstanding 2009–2025
Ligand Pharmaceuticals Incorporated (LGND) annual shares outstanding by fiscal year, computed from SEC filings.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 19.8M | +3.5% |
| FY 2024 | 19.1M | +8.8% |
| FY 2023 | 17.6M | +3.6% |
| FY 2022 | 17.0M | +1.1% |
| FY 2021 | 16.8M | +4.3% |
| FY 2020 | 16.1M | -4.4% |
| FY 2019 | 16.8M | -19.0% |
| FY 2018 | 20.8M | -1.8% |
| FY 2017 | 21.1M | +1.1% |
| FY 2016 | 20.9M | +4.8% |
| FY 2015 | 19.9M | +1.9% |
| FY 2014 | 19.6M | -4.4% |
| FY 2013 | 20.5M | -3.8% |
| FY 2012 | 21.3M | +2.9% |
| FY 2011 | 20.7M | — |
| FY 2010 | 0.0M | — |
| FY 2009 | 0.0M | — |
Source: Ligand Pharmaceuticals Incorporated SEC filings — balance sheet (10-K), split-adjusted. Refreshed nightly.
See the full picture for Ligand Pharmaceuticals Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeLigand Pharmaceuticals Incorporated — frequently asked questions
What is Ligand Pharmaceuticals Incorporated's shares outstanding?
Ligand Pharmaceuticals Incorporated (LGND) reported shares outstanding of 19.8M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Ligand Pharmaceuticals Incorporated's official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.